Roger Geiger Lab retweeted
Our Biochemistry Focus webinar series is back on 10 September! Join us delving into @RGeigerlab's research on immune responses to tumours using systems biology approaches and discuss novel approaches to modulating T cell activity and tumour metabolism ow.ly/VIKQ50WRj4P
Roger Geiger Lab retweeted
NEW Review: The roles of arginases and arginine in immunity
bit.ly/3zZZMUL
by Stefania Canè, Roger Geiger & Vincenzo Bronte @iov_irccs @BellinzonaIrb
describes how arginases and their metabolites contribute to immune dysfunction in various diseases
Roger Geiger Lab retweeted
If you're interested in anti-tumor immunity and metabolism... Arg:Orn ⚖️ TAM/CD8
Article:
nature.com/articles/s43018-0…
News and Views: nature.com/articles/s43018-0…
Check out our review on engineering bacteria for cancer immunotherapy sciencedirect.com/science/ar…
Exciting conference on Microbes & Cancer in beautiful Madrid on June 13 – 14. cnb.csic.es/index.php/en/eve…
Roger Geiger Lab retweeted
Replying to @BSI_immunomet
@BSI_immunomet's #UKimmunomet24 meeting will be packed with cutting-edge #immunometabolism #research & an excellent speaker line up 🙌
There will also be plenty of opportunities for #ECRs to share their work 🚀
Submit your abstract by Friday 8 March 👉bit.ly/3TUBIKl
Thrilled to share that our TCR-PREDICT project has been funded by the #ERCCoG program. Huge thanks to the team for their tremendous effort, to INGM, @BellinzonaIrb, and our reviewers for their support. 🙏
📢 Results of the 2023 ERC Consolidator Grant competition are out.
€627 million for 308 researchers.
Who has been offered funding?
What topics and questions will they investigate?
Where will they conduct their research?
🇪🇺@HorizonEU #ERCCoG news 👉 europa.eu/!qvtkcH
Roger Geiger Lab retweeted
📢@IMMERGE_MSCA_DN is a #MSCActions #DoctoralNetwork (DN) aiming to train a New Generation of Scientists in Europe in #immunology, #multiomics & #GeneEditing to fight against #PrimaryImmunodeficiencies
We just opened the call! 📯 📯 📯
Find out more 🔎
👉immergeproject.eu
Excited to share our recent study on immune cell proteomes in liver cancer, now published in @CellGenomics.
cell.com/cell-genomics/fullt…
Proteomics data are now publicly accessible at immunomics.ch/hcc/
A thread about our findings on T cells and macrophages in tumors (1/6)
5/6 Great collaboration with
Giorgio Ercolani, Nuh Rahbari, Sara De Dosso, Carlo Catapano, Henrik Mueller, Nadege Pelletier
@Acristaudi
@Silke_Gillessen
@seifertlab
@SchlapbachLab
@JekerLab
6/6 Congrats to first authors @CanaleFer @JuliaNeu2010 and everybody involved in the study
including @ZoppiGiada @GaiaAntonini1 @IanVogel4
And many thanks to
@ERC_Research
@krebsliga and RPF program for funding
Roger Geiger Lab retweeted
30.11.: Metabolism-based Cancer Therapy Symposium (online) – Cancer cells have a different metabolism than normal cells and thus offer promising therapeutic targets. We will present and discuss these with you ➡️ mbct-symposium.com/ #mbct22 @dkfz @Medizin_TUD @RGeigerlab
Roger Geiger Lab retweeted
We present to you the 3 winners of Maria Begnudelli Award of 33rd Pezcoller Symposium! Congratulations to Andrea Casagranda from @USI_university, @beatrice_casati from @UniHeidelberg and Simona Fusco from @SanRaffaeleMI
Feeling excited after an inspiring lab retreat with a great team in beautiful Centovalli. Thanks to @EMBO_YIP for supporting this event.
Roger Geiger Lab retweeted
Join the @dgfi_org Translational Immunology School at Potsdam, on June 30- July 2, 2022. Great success stories with participants from both academic as well as clinical research institutions & industry.
Info & registration 👉dgfi.org/akademie-fuer-immun…
Roger Geiger Lab retweeted
🟠 SCIENCE |
On Thursday 13th we will be connected to the XXI Seminar serie listening to @rgeigerlab from Institute for Research in Biomedicine from Switzerland at 15.30h
Click here
ibis-sevilla.es/agenda/semin…






















